✦ LIBER ✦

Should we abstain from Gleason score 2–4 in the diagnosis of prostate cancer? Results of a German multicentre study

✍ Scribed by Sabine Brookman-May; Matthias May; Wolf-Ferdinand Wieland; Steffen Lebentrau; Sven Gunia; Stefan Koch; Christian Gilfrich; Jan Roigas; Bernd Hoschke; Maximilian Burger

Book ID: 106033572
Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 326 KB
Volume: 30
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s00345-010-0632-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Degarelix: A Novel Gonadotropin-Releasin

Degarelix: A Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker—Results from a 1-yr, Multicentre, Randomised, Phase 2 Dosage-Finding Study in the Treatment of Prostate Cancer

✍ Hendrik Van Poppel; Bertrand Tombal; Jean J. de la Rosette; Bo-Eric Persson; Jen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 647 KB

Clinical performance of serum prostate-s

Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS

✍ Lazzeri, Massimo; Haese, Alexander; Abrate, Alberto; de la Taille, Alexandre; Re 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB

Editorial Comment on: Degarelix: a Novel

Editorial Comment on: Degarelix: a Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker—Results from a 1-yr, Multicentre, Randomised, Phase 2 Dose-Finding Study in the Treatment of Prostate Cancer

✍ Patrick J. Bastian 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Editorial Comment on: Degarelix: A Novel

Editorial Comment on: Degarelix: A Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker—Results from a 1-yr, Multicentre, Randomised, Phase 2 Dose-Finding Study in the Treatment of Prostate Cancer

✍ Peter Whelan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

MP46-17 THE IMPACT OF PATHOLOGICAL GLEAS

MP46-17 THE IMPACT OF PATHOLOGICAL GLEASON SCORE ON BIOCHEMICAL RECURRENCE IN PATIENTS WITH PATHOLOGICALLY ORGAN-CONFINED T2 PROSTATE CANCER AND POSITIVE SURGICAL MARGINS: CAN WE JUSTIFY EXPECTANT MANAGEMENT OR IS ADJUVANT RADIATION THERAPY INDICATED? RESULTS OF A MULTICENTER EUROPEAN EVALUATION

✍ Karl, Alexander; Buchner, Alexander; Stief, Christian; Tympner, Christiane; Kirc 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 42 KB